Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • Glycominds Joins Biomolecular Photonic Consortium
Sep 2007
Biodiagnostics company Glycominds Ltd. of Lod, Israel, maker of a blood test for detecting inflammatory bowel disease and the severity of Crohn's disease, announced this week it has joined the Biomolecular Photonic (BMP) Consortium. "Glycominds' glycan biomarker technology stands out as innovative and unique, providing the consortium with proven biomarkers for Crohn's disease and a great opportunity for diagnosing colorectal cancer," said Dr. Elisha Rabinovitz, the head of the BMP consortium and chief scientist for Given Imaging Ltd. BMP is a new, three-year consortium funded by the government of Israel to improve in vivo imaging diagnostics for Crohn's disease and colorectal cancer. The consortium has received $4 million in funding for its first year. 

The technology of generating and harnessing light and other forms of radiant energy whose quantum unit is the photon. The science includes light emission, transmission, deflection, amplification and detection by optical components and instruments, lasers and other light sources, fiber optics, electro-optical instrumentation, related hardware and electronics, and sophisticated systems. The range of applications of photonics extends from energy generation to detection to communications and...
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.